• 2017

    126. Y. Fang, W. Yang, L. Cheng, F. Meng, J. Zhang, Z. Zhong, EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo, Acta Biomater, 64 (2017) 323-333. 126.pdf

    125. Z. Zhong, Innovative Polymers for Controlled Release Applications, Biomacromolecules, 18 (2017) 3652-3653. 125.pdf

    124. W. Yang, Y. Xia, Y. Zou, F. Meng, J. Zhang, Z. Zhong, Bioresponsive Chimaeric Nanopolymersomes Enable Targeted and Efficacious Protein Therapy for Human Lung Cancers in Vivo, Chemistry of Materials, 29 (2017) 8757-8765. 124.pdf

    123. C. Hang, Y. Zou, Y. Zhong, Z. Zhong, F. Meng, NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery, Colloids and Surfaces B: Biointerfaces, 158 (2017) 547-555. 123.pdf

    122. Y. Zhu, J. Zhang, F. Meng, C. Deng, R. Cheng, J. Feijen, Z. Zhong, cRGD/TAT Dual-Ligand Reversibly Cross-Linked Micelles Loaded with Docetaxel Penetrate Deeply into Tumor Tissue and Show High Antitumor Efficacy in Vivo, ACS Appl Mater Interfaces, 9 (2017) 35651-35663. 122.pdf

    121. Y. Zou, M. Zheng, W. Yang, F. Meng, K. Miyata, H.J. Kim, K. Kataoka, Z. Zhong, Virus-Mimicking Chimaeric Polymersomes Boost Targeted Cancer siRNA Therapy In Vivo, Advanced Materials, 29 (2017) 1703285. 121.pdf

    120. M. Qiu, J. Ouyang, H. Sun, F. Meng, R. Cheng, J. Zhang, L. Cheng, Q. Lan, C. Deng, Z. Zhong, Biodegradable Micelles Based on Poly(ethylene glycol)-b-polylipopeptide Copolymer: A Robust and Versatile Nanoplatform for Anticancer Drug Delivery, ACS Appl Mater Interfaces, 9 (2017) 27587-27595. 120.pdf

    119. N.J.R. Blackburn, B. Vulesevic, B. McNeill, C.E. Cimenci, A. Ahmadi, M. Gonzalez-Gomez, A. Ostojic, Z. Zhong, M. Brownlee, P.J. Beisswenger, R.W. Milne, E.J. Suuronen, Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction, Basic Research in Cardiology, 112 (2017). 119.pdf

    118. J. Chen, J. Ouyang, Q. Chen, C. Deng, F. Meng, J. Zhang, R. Cheng, Q. Lan, Z. Zhong, EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo, ACS Appl Mater Interfaces, 9 (2017) 24140-24147. 118.pdf

    117. J. Qiu, R. Cheng, J. Zhang, H. Sun, C. Deng, F. Meng, Z. Zhong, Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for Leukemia, Biomacromolecules, 18 (2017) 3207-3214. 117.pdf

    116. H. Meng, Y. Zou, P. Zhong, F. Meng, J. Zhang, R. Cheng, Z. Zhong, A Smart Nano-Prodrug Platform with Reactive Drug Loading, Superb Stability, and Fast Responsive Drug Release for Targeted Cancer Therapy, Macromol Biosci, 17 (2017) 1600518.

    115. P. Zhong, X. Gu, R. Cheng, C. Deng, F. Meng, Z. Zhong, αvβ3 integrin-targeted micellar mertansine prodrug effectively inhibits triple-negative breast cancer in vivo, Int J Nanomedicine, Volume 12 (2017) 7913-7921. 115.pdf

    114. Y. Zhu, X. Wang, J. Zhang, F. Meng, C. Deng, R. Cheng, J. Feijen, Z. Zhong, Exogenous vitamin C boosts the antitumor efficacy of paclitaxel containing reduction-sensitive shell-sheddable micelles in vivo, Journal of Controlled Release, 250 (2017) 9-19. 114.pdf

    113. K. Wu, R. Cheng, J. Zhang, F. Meng, C. Deng, Z. Zhong, Micellar nanoformulation of lipophilized bortezomib: high drug loading, improved tolerability and targeted treatment of triple negative breast cancer, Journal of Materials Chemistry B, 5 (2017) 5658-5667. 113.pdf

    112. Y. Zhong, F. Meng, C. Deng, X. Mao, Z. Zhong, Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles, Drug Delivery, 24 (2017) 1482-1490.  112.pdf

    111. J.T. Wu, J. Zhang, C. Deng*, F.H. Meng, R. Cheng, and Z.Y. Zhong*, Robust, Responsive and Targeted PLGA Anticancer Nanomedicines by Combining Reductively Cleavable Surfactant and Covalent Hyaluronic Acid Coating, ACS Appl. Mater. Interfaces 2017, DOI: 10.1021/acsami.6b15105   111.pdf

    110. Y. Fang, Y. Jiang, Y. Zou, F.H. Meng*, J. Zhang, C. Deng, H.L. Sun and Z.Y. Zhong*, Targeted glioma chemotherapy by cyclic RGD peptide-functionalized reversibly core-crosslinked multifunctional poly(ethylene glycol)-b-poly(e-caprolactone) micelles, Acta Biomaterialia 2017, http://dx.doi.org/10.1016/j.actbio.2017.01.007   110.pdf

    109. J.T. Wu, C. Deng*, F.H. Meng, J. Zhang, H.L. Sun, and Z.Y. Zhong*, Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer, J. Control. Release 2017,  http://dx.doi.org/10.1016/j.jconrel.2016.12.024   109.pdf.pdf

    108. P. Zhong, H. Meng, J. Qiu, J. Zhang, H.L. Sun, R. Cheng*, and Z.Y. Zhong*,αvβ3 Integrin-Targeted Reduction-Sensitive Micellar Mertansine Prodrug: Superb Drug Loading, Enhanced Stability, and Effective Inhibition of Melanoma Growth In Vivo, J. Control. Release 2017,  DOI: 10.1016/j.jconrel.2016.12.011   108.pdf

    107. Y. Zou, Y.H. Wei, G.L. Wang, F.H. Meng*, M.Y. Gao, G. Storm, and Z.Y. Zhong*, Nano-Polymersomes with an Ultrahigh Iodine Content for High-Performance X-Ray Computed Tomography Imaging In Vivo, Adv. Mater. 2017, http://dx.doi.org/10.1002/adma.201603997   107.pdf

    106. W. Chen, Y. Zou, Z.Y. Zhong*, and R. Haag *, Cyclo(RGD)-decorated Redox-responsive Nanogels Mediate Targeted Chemotherapy of Integrin Over-expressing Human Glioblastoma In Vivo, Small 2017, DOI: 10.1002/smll.201601997   106.pdf

    105. N. Zhang, Y.F. Xia, Y. Zou, W.J. Yang, J. Zhang, Z.Y. Zhong*, and F.H. Meng*, ATN-161 Peptide Functionalized Reversibly Crosslinked Polymersomes Mediate Targeted Doxorubicin Delivery into Melanoma-Bearing C57BL/6 Mice, Mol. Pharm. 2017, DOI: 10.1021/acs.molpharmaceut.6b00800   105.pdf